The Vitamin D Paradox: Why Deficiency Is Common in Sunny Climates and What It Means for Muscle Strength

It sounds like it should not be possible. Oman receives close to year round sunshine, and sunlight on skin is how the body makes most of its vitamin D. Yet study after study across the Gulf region finds that a large share of young, healthy adults are running low. That is not a contradiction so much as a pattern with several interlocking causes, and it matters for this site's focus because low vitamin D status keeps turning up in research on muscle strength, the same muscle strength that, combined with excess body fat, defines sarcopenic obesity. This post works through what vitamin D actually does inside muscle tissue, why deficiency persists despite the sunshine, what randomized controlled trials do and do not show about supplementation, and why the connection to excess adiposity is more direct than it might first appear.

The Sunshine Paradox in the Gulf

A 2024 study published in Cureus by Jamali, Abdeen, and Mathew measured 25-hydroxyvitamin D, the standard blood marker of vitamin D status, in 201 healthy medical and dental students at Kuwait University. The result was stark. Vitamin D deficiency, defined as a level below 50 nmol/L, was found in 171 participants, or 85.1 percent of the group. Only 6.5 percent had what the study classified as optimal levels. Deficiency was slightly more common in male students than female students in this particular cohort, and it was significantly worse among students in their non clinical academic years compared with those in later, more clinically active years, which the authors linked to how much time each group spent indoors.

Closer to home, a 2026 retrospective analysis in Cureus by Alswaii and colleagues reviewed five years of vitamin D testing requests from primary healthcare institutes across North Batinah, Oman, covering 3,081 patients tested between 2018 and 2022. Vitamin D insufficiency was most common among young adult women, at 14.9 percent, while older adults showed markedly higher sufficiency rates by comparison. The authors suggested this pattern may reflect more consistent clinical monitoring and supplementation among older adults, alongside lifestyle factors such as reduced outdoor activity and increased indoor living among younger adults, rather than any lack of available sunlight.

The explanation researchers keep converging on is behavioral, not meteorological. Modern young adult life in the Gulf, as elsewhere, is spent largely indoors: lecture halls, offices, cars, malls, and homes with air conditioning running against the heat. Covering clothing, sunscreen use, and simply avoiding the midday sun because of its intensity all further cut down on the ultraviolet B exposure the skin needs to synthesize vitamin D. The sun being available does not mean it is being used, and the gap between potential and actual exposure appears to be where most of this deficiency originates.

What Vitamin D Actually Does Inside Muscle

Vitamin D is best known for regulating calcium and bone health, but skeletal muscle turns out to have its own vitamin D receptor (VDR), and that receptor does real work. A 2020 study in The Journal of Physiology by Bass and colleagues used a targeted, muscle specific knockdown of the VDR in rats, avoiding the confounding calcium problems that come with older whole body knockout models, and then studied both the muscle tissue directly and muscle cells growing in a dish. When the VDR was knocked down in living muscle, the muscle fibers atrophied, meaning they lost total protein content and shrank in cross sectional area. This happened through increased autophagy, the cell's internal recycling and breakdown process, rather than through any change in how much new protein the muscle was building. The knockdown also caused widespread down regulation of genes involved in mitochondrial function, the cell's energy producing machinery. In a separate set of experiments using muscle cells in culture, knocking down the VDR impaired the cells' ability to properly differentiate into mature muscle fibers in the first place. Together, this points to the VDR playing a genuinely independent, structural role in maintaining muscle mass and quality, not just a downstream side effect of vitamin D's better known role in bone and calcium.

It is worth being direct about what kind of evidence this is. This study was conducted in rats and in cultured mouse muscle cells, not in humans, so it demonstrates a plausible biological mechanism rather than proving the same chain of events happens identically in a person. It does, however, help explain why human trials keep finding effects specifically on muscle strength and function, discussed below, rather than the story being purely about bone.

Why Excess Body Fat Compounds the Problem

This is the piece that connects vitamin D most directly to sarcopenic obesity rather than to muscle health in general. A 2026 review in the journal Obesities by Jirků, Kršáková, and Křížová lays out why people carrying more body fat tend to have lower circulating vitamin D even when their sun exposure and intake are identical to leaner people. Two mechanisms, not mutually exclusive, explain most of it. The first is sequestration: vitamin D is fat soluble, and adipose tissue acts as a storage depot that holds onto a meaningful share of it, making it less immediately available in the bloodstream. The second, which the review's cited evidence suggests actually carries more explanatory weight, is volumetric dilution: vitamin D taken in through sun exposure or supplementation gets distributed across a person's entire body mass, both fat and lean tissue, so someone with a larger total body volume ends up with the same absolute amount of vitamin D spread more thinly, producing a lower blood concentration. The review also cites a meta-analysis, drawn mainly from European and North American cohorts, finding that each one unit increase in BMI is associated with roughly a 1.15 percent decrease in serum vitamin D. Practically, this means that someone with excess adiposity, including the normal weight but high body fat pattern common in early sarcopenic obesity, may need meaningfully more vitamin D from sun or supplementation to reach the same blood level as someone with less fat mass, even before muscle related mechanisms are considered at all.

What Controlled Trials Actually Show

Mechanism and association are one thing; whether giving people vitamin D actually improves muscle outcomes in a controlled trial is another, and here the picture is genuinely mixed rather than a clean win. A 2021 network meta-analysis in Nutrients by Cheng, Chen, Chen, Chu, and Kang pooled nine randomized controlled trials, totaling 1,420 participants, that tested combinations of vitamin D, protein, and exercise for treating sarcopenia. Vitamin D supplementation alone was associated with a shorter chair stand test time (a functional measure of lower body strength and power), with a weighted mean difference of negative 1.32 seconds. However, vitamin D alone showed no significant effect on gait speed or on any measure of muscle mass. The clearest benefit in the whole analysis came from combining all three interventions: vitamin D plus protein plus exercise produced a significantly greater improvement in hand grip strength than an iso-caloric control, with a weighted mean difference of 3.86 kilograms, and also showed a trend toward increasing muscle mass, though that particular result did not reach statistical significance on its own.

The pattern that emerges across this and related meta-analyses is consistent: vitamin D by itself tends to move strength and functional measures like grip strength or chair stand time more reliably than it moves muscle size. Meaningful gains in both strength and mass generally require pairing vitamin D with adequate protein intake and, ideally, a structured resistance exercise program, echoing this site's earlier coverage of why more protein alone is not a complete fix for muscle loss and of how resistance training dose relates to muscle outcomes. Vitamin D appears to function less as a standalone muscle builder and more as a necessary supporting condition, correcting a deficiency that would otherwise blunt the muscle's response to the interventions that do the heavier lifting.

Practical Implications

For a young adult in Oman or elsewhere in the Gulf, the practical takeaway is not that sunshine is irrelevant, but that living somewhere sunny is not, by itself, a reliable guarantee of adequate vitamin D status, especially for anyone who spends most daylight hours indoors, covers up outdoors, or is carrying excess body fat. A blood test for 25-hydroxyvitamin D is a simple, direct way to find out where someone actually stands rather than assuming sunny geography has already solved the problem. For anyone found to be deficient, the trial evidence suggests that correcting the deficiency is worth doing for general health regardless, but that expecting vitamin D correction alone to meaningfully rebuild muscle mass is not well supported. Pairing it with adequate protein intake and resistance training, per this site's complete guide to sarcopenic obesity in young adults, is what the strongest trial evidence actually points to.

Limitations and What Remains Uncertain

Several caveats apply. The mechanistic evidence for the VDR's role in muscle atrophy comes from rodent and cell culture models, and while highly informative about plausible biology, it cannot be assumed to translate one to one into human muscle physiology. The network meta-analysis pooling nine RCTs found genuine benefits for functional strength measures but explicitly did not find a significant standalone effect of vitamin D on muscle mass, and the trials included varied in vitamin D dose (100 to 1600 IU per day across the broader literature), baseline vitamin D status of participants, and study duration, all of which can shift results. The obesity and vitamin D distribution literature is drawn mostly from European and North American populations, and while the underlying biology of fat soluble vitamin storage is not likely to differ by ethnicity, region specific confirmation in Gulf populations is still limited. Finally, none of the vitamin D and muscle strength trials discussed here were conducted specifically in young Omani or Gulf adults, or in people who meet full diagnostic criteria for sarcopenic obesity rather than general sarcopenia, so the practical translation to this site's specific population remains an area where more direct regional research, including the kind this site's affiliated project is working toward, would add real value.

Connecting Back to Sarcopenic Obesity

Vitamin D deficiency and excess adiposity are not two separate problems that happen to coexist in the same person. The evidence reviewed here suggests they actively reinforce each other: more body fat lowers circulating vitamin D through dilution and storage effects, and low vitamin D status is mechanistically linked, at least in animal and cell models, to the kind of muscle atrophy that defines the sarcopenia half of sarcopenic obesity. For a population like young Gulf adults, where high rates of vitamin D deficiency coexist with rising rates of obesity and sedentary indoor lifestyles, this is a genuinely relevant and correctable piece of the picture, even if it is not, on its own, a complete solution. This post is for general education and is not medical advice. A vitamin D blood test and its interpretation should be discussed with a qualified healthcare provider.

References

• Nutrients (2021) — Cheng, Chen, Chen, Chu, and Kang: The Optimal Strategy of Vitamin D for Sarcopenia, a Network Meta-Analysis of Randomized Controlled Trials
• Cureus (2024) — Jamali, Abdeen, and Mathew: Prevalence of Vitamin D Deficiency Among Healthy Young Adults at Kuwait University
• Cureus (2026) — Al Maqbali, Alswaii et al.: Vitamin D Status and Test Utilization, A Five-Year Analysis
• The Journal of Physiology (2020) — Bass et al.: The Mechanisms of Skeletal Muscle Atrophy in Response to Transient Knockdown of the Vitamin D Receptor In Vivo
• Obesities (2026) — Jirků, Kršáková, and Křížová: Vitamin D in Obesity, Mechanisms and Clinical Impact